Physician profile
Shitel D Patel
NPI 1023219623
$44,359.48
in general payments reported to CMS, 2019-2025
16 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,043 · 2020: $150 · 2021: $163 · 2022: $1,285 · 2023: $128 · 2024: $39K · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $39K · Food and Beverage: $813.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $38,905.96 |
| Food and Beverage | $812.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Health Care Systems INC. | $38,905.96 | 2024 | |
| Allergan, INC. | $3,000.53 | 2019-2022 | |
| Becton, Dickinson and Company | $1,050.00 | 2022 | |
| Tela Bio, INC. | $377.26 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Davol INC. | $151.87 | 2022 | |
| Medtronic USA, INC. | $150.00 | 2020 | |
| Galderma Laboratories, L.P. | $131.93 | 2019-2024 | |
| Merz North America, INC. | $122.03 | 2024 | |
| Mentor Worldwide LLC | $81.14 | 2021-2023 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Abbvie INC. | $78.61 | 2023-2025 | |
| Motiva USA, LLC | $75.00 | 2025 | |
| Musculoskeletal Transplant Foundation INC. | $70.55 | 2019 | |
| Kci USA, INC. | $66.16 | 2019-2023 | |
| Vertex Pharmaceuticals Incorporated | $52.97 | 2025 | |
| Integra Lifesciences Corporation | $33.20 | 2022-2025 | Integra, Surgimend, Integra Dermal Regeneration Template |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $12.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shitel Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.